| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817936 | Clinical Biochemistry | 2013 | 6 Pages |
Abstract
We have validated a sensitive ELISA assay for urinary TGF-β1, and demonstrated correlations with the degree of proteinuria and higher levels in patients with DN compared to controls. Additional study will be necessary in order to determine if serial testing can predict renal prognosis independent of known prognostic factors for patients with DN.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Mykola V. Tsapenko, Rosemary E. Nwoko, Timothy M. Borland, Nikolay V. Voskoboev, Axel Pflueger, Andrew D. Rule, John C. Lieske,